146 results on '"Lipton, Richard B."'
Search Results
2. International Classification of Headache Disorders-4 – Work in Progress 1
3. Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults
4. Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine
5. Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial
6. Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension
7. Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care
8. Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials
9. A population-health approach to characterizing migraine by comorbidity: Results from the Mindfulness and Migraine Cohort Study
10. Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition
11. Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial
12. Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial
13. What do people want to know about “Growing Up with Migraine”? Results of a preference survey of people with lived experience to guide future research
14. Measuring headache day severity using multiple features in daily diary designs
15. Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies
16. Efficacy of erenumab in chronic migraine patients with and without ictal allodynia
17. Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II
18. Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
19. Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension
20. Headache complexity (number of symptom features) differentiates post-traumatic from non-traumatic headaches
21. Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications
22. Dizziness and vertigo during the prodromal phase and headache phase of migraine: A systematic review and meta-analysis
23. Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response
24. The prevalence of hypnic headache in Iceland
25. Acute treatment patterns in patients with migraine newly initiating a triptan
26. Focus group findings on the migraine patient experience during research studies and ideas for future investigations
27. Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.
28. Proposed new diagnostic criteria for chronic migraine
29. Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraine
30. Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial
31. Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data
32. Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients
33. Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study
34. Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
35. Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
36. Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
37. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)
38. Pain worsening with physical activity during migraine attacks in women with overweight/obesity: A prospective evaluation of frequency, consistency, and correlates
39. Growth of Headache Research: A 1983–2014 bibliometric study
40. Ecological momentary assessment of the relationship between headache pain intensity and pain interference in women with migraine and obesity
41. A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
42. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program
43. Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)
44. Primary headache: What’s stress got to do with it?
45. Objectively measured physical activity in obese women with and without migraine
46. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results
47. Prevalence of neck pain in migraine and tension-type headache: A population study
48. Chronic rhinitis and its association with headache frequency and disability in persons with migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
49. Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: A randomized study
50. Global perspectives on the burden of episodic and chronic migraine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.